Case Study: AxoSim’s Human Peripheral Co-Culture Assay
News and BlogHigh Throughput, Human Data: AxoSim’s Human Peripheral Co-Culture Assay In addition to our 3D NerveSim™ and BrainSim™ models, AxoSim also performs a variety of cell-based 2D assays including our new Human Schwann Cell and iPSC-derived […]
Read More
Introducing our newest SimLab Service: Human Peripheral Co-Culture Assay
News and BlogIntroducing our newest SimLab Service: Human Co-Culture Peripheral Assay We are excited to launch our newest assay which uses human Schwann cells and iPSC-derived neurons to recapitulate the results one can expect to see from […]
Read More
Dynamic Poster Presentation at Safety Pharmacology Society’s Virtual Meeting
News and BlogOn Wednesday, September 16th at 11:00am EST, AxoSim CEO, Dr. Lowry Curley will be giving a dynamic poster presentation at Safety Pharmacology Society’s (SPS) Annual Meeting, held virtually this year. The poster, #026, is entitled […]
Read More
Support from NIH Crucial to AxoSim’s Development
News and BlogOver 90% of neurological drugs that are successfully tested in animals fail once they reach human clinical trials. Therefore, there is a need for new, clinically relevant, preclinical testing models that mimic the human nervous […]
Read More
Key Takeaways from Webinar: ADCs and Peripheral Neuropathy
News and BlogOn July 28, 2020, AxoSim held a webinar which explored the need for new, predictive assays to better assess ADCs’ effects on peripheral neuropathy. Rakesh Dixit, PhD, DABT, elaborated on his 30 plus years of […]
Read More
Webinar: ADCs and Peripheral Neuropathy: The Need for New, Predictive Assays
News and BlogOn Tuesday, July 28th, AxoSim is hosting a webinar in collaboration with Rakesh Dixit, PhD, DABT, President and CEO of Bionavigen. This interactive webinar, entitled ADCs and Peripheral Neuropathy: The Need for New, Predictive Assays, […]
Read More
Key Takeaways from NerveSim™ and BrainSim™: Platforms for Neurological Drug Discovery and Toxicology Screening
News and BlogOn Tuesday, June 30th, 2020 AxoSim held an interactive webinar: NerveSim™ and BrainSim™: Platforms for Neurological Drug Discovery and Toxicology Screening. Lowry Curley, PhD, and Helena Hogberg, PhD delved into the specifics of two drug […]
Read More
Explore Platforms Mimicking the PNS and CNS at AxoSim’s Webinar on June 30th
News and BlogOn Tuesday, June 30th, at 12pm EST AxoSim will be hosting a Webinar: NerveSim™ and BrainSim™ Platforms for Neurological Drug Discovery and Toxicology Screening. This hour long webinar will explore innovative platforms mimicking the CNS […]
Read More
Webinar: NerveSim™ and BrainSim™: Platforms for Neurological Drug Discovery and Toxicology Screening
News and BlogOn Tuesday, June 30th at 12pm EST, join Helena Hogberg, PhD and Lowry Curley, PhD for an interactive webinar to learn more about innovative platforms for drug discovery mimicking the PNS and CNS. Attendees are […]
Read More
Publication Confirms NerveSim’s Ability to Recapitulate Peripheral Neuropathy
News and BlogMay 11, 2020 Recent publication in ALTEX demonstrates prediction of clinical peripheral neuropathy by chemotherapeutic drugs using NerveSim™ powered by Nerve-on-a-Chip® Using AxoSim’s NerveSim™ Peripheral Neuropathy Assay, AxoSim scientists showed distinct, mechanistic readouts of four […]
Read More